Germany’s Curevac to include virus variants in vaccine trials

Negative mood linked to prolonged amygdala activity
22 March 2021
Cancer screenings rebounded quickly after drop at start of pandemic
22 March 2021

Germany’s Curevac to include virus variants in vaccine trials

German group Curevac said Monday it will broaden its mRNA COVID vaccine trials to include new virus variants as it aims to file for EU approval in the second quarter.

Comments are closed.